26/10/2021 - Press release
The risk of death from any cause increases by 30% for each 10 beat per minute increase above 70 beats per minute The study, led by researchers at the Hospital del Mar Medical Research Institute, analysed data from more than 10,000 participants in the REGICOR study to establish the relationship between heart rate and the risk of cardiovascular disease and death It is a simple measurement indicator, which also provides information on the risk of cardiovascular disease. The work has been published in the European Journal of Preventive Cardiology
Més informació "A higher heart rate is associated with a greater risk of death"
21/10/2021 - General information
The Spanish Society of Epidemiology (SEE) in its XVII edition has awarded the "Prize for research by young researchers. Edition 2021: Miguel Carrasco" to Natàlia Soldevila-Domènech, predoctoral researcher of the Integrative Pharmacology and Systems Neuroscience research group at IMIM, for the project "Analysis of trajectories of cognition evaluated in a continuous manner with cognitive training tasks in older adults at risk of Alzheimer 's disease". The work aims to evaluate the feasibility, validity and reliability of a measure of cognition obtained from the performance on self?administered computerized cognitive training tasks, and to identify and characterize subgroups of elderly individuals following a similar cognitive trajectory during the course of a preventive intervention for cognitive decline (PENSA Study).
20/10/2021 - General information
Patients with chronic kidney disease treated with bisphosphonates have a 15% higher risk of disease progression, although it is not linked to a higher rate of acute kidney injury, gastrointestinal events or hypocalcaemia. The study warns of the importance of assessing the stage of severity of CKD before prescribing bisphosphonates, as "They can worsen renal function and, in these cases, alternative treatments should be sought."
19/10/2021 - Press release
Activating a molecule present in the membrane of NK lymphocytes (Natural Killer cells) makes them resistant to the immunosuppressive mechanisms of HER2-positive breast tumours and enhances their antitumour action. Combining standard treatments for HER2-positive breast cancer with drugs that target this molecule in NK cells could increase their clinical efficacy. This paves the way for a new approach to treating this type of tumour with immunotherapy This has been demonstrated in a collaborative study led by researchers at the Hospital del Mar Medical Research Institute, published in the journal Cancer Immunology Research
18/10/2021 - General information
These new grants are linked to the Spanish Government's Recovery, Transformation and Resilience Plan and are co-financed by the European Union's Next Generation funds. Four projects involving the IMIM will benefit. Four research projects led by or involving researchers from the Hospital del Mar Medical Research Institute (IMIM) will receive funding from the State Research Agency (Agència Estatal d'Investigació), as part of the aid promoted in Spanish and European plans linked to recovery from the COVID-19 pandemic. In total of, each project will receive just over 790,000 euros from these funds.
15/10/2021 - General information
From October 18 to 23, the PRBB and its centers invite you to participate in the open day of the Barcelona Biomedical Research Park and get inside the research they do. This time the format will be hybrid and will combine premieres, streaming activities and the first face-to-face event after the pandemic, a round table on the importance of the gender perspective in biomedical research. Throughout the week we will present a series of short videos from the different centers on Neuropharmacology, Cell Biology, Biobanks, Evolution and Cancer that will be released on the PRBB Youtube channel. On the same channel we will make live visits to laboratories investigating the effects of air pollution, synthetic biology and CRISPR, blood stem cells, proteomics and 3D microscopy. And fromInstagram we will broadcast live interviews between three researchers / as and three Instagramers, specialized in science.
These are obese patients with no associated diseases, referred to as metabolically healthy, who account for one in five people who undergo bariatric surgery. Their levels of cholesterol, glucose, triglycerides and fatty liver markers continue to fall five years after surgery The improvement is less than that seen in obese patients who do have metabolic problems prior to undergoing surgery and who, therefore, start from higher levels, but it demonstrates the usefulness of applying this surgical procedure to these individuals This has been demonstrated in a study by the Endocrinology and Nutrition Service at Hospital del Mar, the first in Spain, published in the journal Surgery for Obesity and Related Diseases
Més informació "Bariatric surgery improves long-term health of metabolically healthy obese patients"
13/10/2021 - Institutional news
The Hospital del Mar Medical Research Institute is once again holding its annual meeting to update on the progress made and to highlight the talent of its researchers. After a year and a half marked by the Covid-19 pandemic, the Hospital del Mar Medical Research Institute (IMIM) has recovered its Scientific Retreat, the first face-to-face event since the outbreak of SARS-CoV-2. A new opportunity "to learn about the latest advances made by the institution's research groups, share experiences and seek new avenues for collaboration", as explained during the opening ceremony by the director of IMIM, Dr. Joaquín Arribas. The day got underway with an exceptional round table. Dr. Josep Tabernero, director of the Vall d'Hebron Institute of Oncology (VHIO) and head of the Medical Oncology Service of the Vall d'Hebron University Hospital, and Dr. Eduard Batlle, ICREA researcher at the Barcelona Institute for Research in Biomedicine (IRB), former IMIM researcher and current King Jaime I award winner, analyzed translational research, in a debate moderated by Dr. Jordi Camí, director of the Barcelona Biomedical Research Park (PRBB).
Més informació "The IMIM Scientific Retreat, an opportunity to promote research"
08/10/2021 - Institutional news
The IMIM Foundation announces one open position for a Recognised Researcher (R4) with the objective of incorporating an international leader researcher to one of the main research areas of IMIM: Cancer, Epidemiology and Public Health, Clinical Translation, Biomedical Informatics, or Neurosciences. Incorporation to the IMIM Foundation will be through a permanent full-time work contract. The mission of the job is to carry out research of excellence and to achieve effective transfer of this to the most important health problems in the population, observing, at all times, the Institute's Code of Good Practice and Code of Ethics.
05/10/2021 - General information
With this new group, the Carlos III Health Institute's Networked Biomedical Research Centre aims to unite Spain's scientific excellence in this field to enable better funding in emerging diseases, such as COVID-19, and other research areas, including antimicrobial resistance and HIV-AIDS, in which Hospital del Mar and IMIM researchers have a great deal of experience. The Infectious Pathology and Antimicrobial Research Group (IPAR) at the Hospital de Mar Medical Research Institute (IMIM) will form part of the new CIBER on Infectious Diseases. The purpose of this new group is to promote research in this field in Spain by offering new structural funding tools.
Més informació "Hospital del Mar and IMIM to participate in the new CIBER on infectious diseases"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact